These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22714061)

  • 1. The expression and prognosis of FOXO3a and Skp2 in human ovarian cancer.
    Lu M; Zhao Y; Xu F; Wang Y; Xiang J; Chen D
    Med Oncol; 2012 Dec; 29(5):3409-15. PubMed ID: 22714061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression and prognosis of FOXO3a and Skp2 in human hepatocellular carcinoma.
    Lu M; Ma J; Xue W; Cheng C; Wang Y; Zhao Y; Ke Q; Liu H; Liu Y; Li P; Cui X; He S; Shen A
    Pathol Oncol Res; 2009 Dec; 15(4):679-87. PubMed ID: 19404778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression and significance of pThr32-FOXO3a in human ovarian cancer.
    Lu M; Xiang J; Xu F; Wang Y; Yin Y; Chen D
    Med Oncol; 2012 Jun; 29(2):1258-64. PubMed ID: 21452041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of FOXO3a suggests good prognosis of patients with radically resected gastric cancer.
    Yu S; Yu Y; Sun Y; Wang X; Luo R; Zhao N; Zhang W; Li Q; Cui Y; Wang Y; Li W; Liu T
    Int J Clin Exp Pathol; 2015; 8(3):2963-70. PubMed ID: 26045805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low expression of Foxo3a is associated with poor prognosis in ovarian cancer patients.
    Fei M; Zhao Y; Wang Y; Lu M; Cheng C; Huang X; Zhang D; Lu J; He S; Shen A
    Cancer Invest; 2009 Jan; 27(1):52-9. PubMed ID: 19160093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and prognosis of FOXO3a and HIF-1α in nasopharyngeal carcinoma.
    Shou Z; Lin L; Liang J; Li JL; Chen HY
    J Cancer Res Clin Oncol; 2012 Apr; 138(4):585-93. PubMed ID: 22209974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of PH Domain Leucine-rich Repeat Protein Phosphatase, Forkhead Homeobox Type O 3a and RAD51, and their Relationships with Clinicopathologic Features and Prognosis in Ovarian Serous Adenocarcinoma.
    Zhang J; Wang JC; Li YH; Wang RX; Fan XM
    Chin Med J (Engl); 2017 Feb; 130(3):280-287. PubMed ID: 28139510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foxo3a transcription factor is a negative regulator of Skp2 and Skp2 SCF complex.
    Wu J; Lee SW; Zhang X; Han F; Kwan SY; Yuan X; Yang WL; Jeong YS; Rezaeian AH; Gao Y; Zeng YX; Lin HK
    Oncogene; 2013 Jan; 32(1):78-85. PubMed ID: 22310285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expressions of Cx43 and Skp2 in epithelial ovarian tumor and their clinical significances].
    Hu YQ; Liu YJ
    Ai Zheng; 2005 Jan; 24(1):104-9. PubMed ID: 15642212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of Skp2 expression, alone and combined with Jab1 and p27 in epithelial ovarian tumors.
    Sui L; Dong Y; Watanabe Y; Yamaguchi F; Sugimoto K; Tokuda M
    Oncol Rep; 2006 Apr; 15(4):765-71. PubMed ID: 16525656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SKP2/P27Kip1 pathway is associated with Advanced Ovarian Cancer in Saudi Patients.
    Hafez MM; Alhoshani AR; Al-Hosaini KA; Alsharari SD; Al Rejaie SS; Sayed-Ahmed MM; Al-Shabanah OA
    Asian Pac J Cancer Prev; 2015; 16(14):5807-15. PubMed ID: 26320455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foxo3a expression is a prognostic marker in breast cancer.
    Jiang Y; Zou L; Lu WQ; Zhang Y; Shen AG
    PLoS One; 2013; 8(8):e70746. PubMed ID: 23967095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skp2 overexpression is a prognostic factor in patients with ovarian adenocarcinoma.
    Shigemasa K; Gu L; O'Brien TJ; Ohama K
    Clin Cancer Res; 2003 May; 9(5):1756-63. PubMed ID: 12738731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXO3a expression is associated with lymph node metastasis and poor disease-free survival in triple-negative breast cancer.
    Rehman A; Kim Y; Kim H; Sim J; Ahn H; Chung MS; Shin SJ; Jang K
    J Clin Pathol; 2018 Sep; 71(9):806-813. PubMed ID: 29588373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyploid giant cancer cells with budding and the expression of cyclin E, S-phase kinase-associated protein 2, stathmin associated with the grading and metastasis in serous ovarian tumor.
    Lv H; Shi Y; Zhang L; Zhang D; Liu G; Yang Z; Li Y; Fei F; Zhang S
    BMC Cancer; 2014 Aug; 14():576. PubMed ID: 25106448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of forkhead box M1 is associated with aggressive phenotype and poor prognosis in estrogen receptor-positive breast cancer.
    Ahn H; Sim J; Abdul R; Chung MS; Paik SS; Oh YH; Park CK; Jang K
    J Korean Med Sci; 2015 Apr; 30(4):390-7. PubMed ID: 25829806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of skp2 correlates with poor prognosis in endometrial endometrioid adenocarcinoma.
    Kamata Y; Watanabe J; Nishimura Y; Arai T; Kawaguchi M; Hattori M; Obokata A; Kuramoto H
    J Cancer Res Clin Oncol; 2005 Sep; 131(9):591-6. PubMed ID: 16080017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aurora-A/FOXO3A/SKP2 axis promotes tumor progression in clear cell renal cell carcinoma and dual-targeting Aurora-A/SKP2 shows synthetic lethality.
    Li P; Chen T; Kuang P; Liu F; Li Z; Liu F; Wang Y; Zhang W; Cai X
    Cell Death Dis; 2022 Jul; 13(7):606. PubMed ID: 35831273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations of Foxo3 and Foxo4 expressions with clinicopathological features and prognosis of bladder cancer.
    Wang Y; Kang XL; Zeng FC; Xu CJ; Zhou JQ; Luo DN
    Pathol Res Pract; 2017 Jul; 213(7):766-772. PubMed ID: 28554751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deacetylation of FOXO3 by SIRT1 or SIRT2 leads to Skp2-mediated FOXO3 ubiquitination and degradation.
    Wang F; Chan CH; Chen K; Guan X; Lin HK; Tong Q
    Oncogene; 2012 Mar; 31(12):1546-57. PubMed ID: 21841822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.